High rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter syndrome

High rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter syndrome

Saved in:

Bibliographic Details
Main Authors:	Georgios Pongas, Maryam Alasfour, Daniel P. Cassidy, Juan P. Alderuccio, Joseph D. Rosenblatt, Izidore S. Lossos
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952925002538
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia
by: Raji E Joseph, et al.
Published: (2024-12-01)

NEW GENERATION BTK INHIBITORS AND RESISTANCE IN CLL TREATMENT
by: Aysun Gönderen
Published: (2024-12-01)

BTK inhibitors are a possible emerging therapeutic target for gastric cancer
by: José Darío Portillo-Miño, et al.
Published: (2025-03-01)

Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment
by: Laura R. Naydovich, et al.
Published: (2025-07-01)

Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach?
by: Eirini Solia, et al.
Published: (2024-12-01)

PO50 | Treatment with BTK inhibitors in patients affected by chronic lymphocytic leukemia: safety and hemostasis
Published: (2025-08-01)

Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence
by: Amirhossein Heidari, et al.
Published: (2025-01-01)

The contribution of BTK signaling in myeloid cells to neuroinflammation
by: Claudia Bassani, et al.
Published: (2025-06-01)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
by: Preetesh Jain, et al.
Published: (2023-10-01)

Peyton E. Richter (ed.), Utopia/Dystopia
by: Ute Schmidt Osmanczik
Published: (2018-11-01)

Transcriptomic profiling in canine B-cell lymphoma supports a synergistic effect of BTK and PI3K inhibitors
by: Xenia Lainscsek, et al.
Published: (2025-04-01)

Richter's transformation presenting with superior vena cava syndrome
by: Nuri Karadurmus, et al.
Published: (2017-07-01)

The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil
by: Teng Fong Ng, et al.
Published: (2020-01-01)

Lisocabtagene Maraleucel for Richter's Transformation—A Case Series
by: Courtney J. Smith, et al.
Published: (2025-04-01)

Hodgkin's variant of richter's transformation: Is transplant always an answer?
by: Ilavarasi Vanidassane, et al.
Published: (2019-01-01)

The tyrosine kinase Btk regulates the macrophage response to Listeria monocytogenes infection.
by: Afitap Derya Köprülü, et al.
Published: (2013-01-01)

Novel BTK Mutation in Patient with Late Diagnosis of X-Linked Agammaglobulinemia
by: Amanpreet Kalkat, et al.
Published: (2023-01-01)

Isolated Richter's syndrome in central nervous system: case report Sindrome de Richter isolada em sistema nervoso central: relato de caso
by: Lucilene S.R. Resende, et al.
Published: (2005-06-01)

Acoustic ejection mass spectrometry: An integrated pipeline for ultra-high throughput screening, reactivity profiling, and potency analysis of covalent BTK inhibitors
by: Ronghai Cheng, et al.
Published: (2025-08-01)

A Rare Cause of Cavitary Lesion in the Lung: Richter’s Transformation
by: Fatma Yıldırım, et al.
Published: (2015-01-01)

Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia
by: Priya Hays
Published: (2025-06-01)

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation
by: Shaomei Feng, et al.
Published: (2025-06-01)

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
by: Adam S. Kittai, et al.
Published: (2025-02-01)

Die zerebrale angiographie. H. Krayenruhl, Und HS. R. Richter
by: O. Lange
Published: (1952-12-01)

Richter's Transformation in an Unusual Site: Non-Hodgkin Lymphoma in the Parotid Region
by: Jyoshitha Jayakumar, et al.

Overcoming PARP Inhibitor and Platinum Resistance with WEE1 Inhibitors in Ovarian Cancer
by: Ilaria Colombo
Published: (2021-10-01)

Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study
by: Lisa M. Hess, et al.
Published: (2022-01-01)

David Richter, Viktorin Kornel ze Všehrd a Chrudim, Chrudim 2020
by: Jan Boukal
Published: (2025-01-01)

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives
by: Yurou Xing, et al.
Published: (2024-12-01)

In Silico Investigation of BTK as a Potent Immunomodulatory Target: Exploring Novel Therapeutic Approaches for Multiple Sclerosis
by: Afsheen Saba, et al.
Published: (2025-07-01)

BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis
by: Ross C. Gruber, et al.
Published: (2024-11-01)

Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
by: E. G. Novikova, et al.
Published: (2014-07-01)

Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein
by: Christian Elledge, et al.
Published: (2024-11-01)

Rapid progression to Richter’s syndrome in a patient with chronic lymphocytic leukemia and near-triploid karyotype
by: Denčić-Fekete Marija, et al.
Published: (2023-01-01)

Glofitamab treatment of Richter transformation with isolated central nervous system involvement: a case report
by: Kang Lu, et al.
Published: (2025-07-01)

Complete response to Mirvetuximab Soravtansine in platinum-resistant recurrent ovarian cancer: a case report
by: Yong Wu, et al.
Published: (2025-03-01)

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
by: Rachel M. Hurley, et al.
Published: (2025-06-01)

Successful treatment of a CLL associated IgM hyper-viscosity syndrome: A rare case
by: Toufic Tannous, et al.
Published: (2024-01-01)

Fatal X-linked agammaglobulinemia complicated by septic shock: a case report and comprehensive review of novel BTK mutations
by: Piaopiao Wu, et al.
Published: (2025-08-01)

ANALYZING EARTHQUAKE ACTIVITY LEVELS IN NORTH SULAWESI USING MAXIMUM LIKELIHOOD METHOD AND GUTENBERG – RICHTER LAW
by: Henry Junus Wattimanela
Published: (2023-06-01)